Pharmacokinetics, tissue distribution and immunomodulatory effect of intralipid formulation of nystatin in mice

Rita Semis, Shai Shmuel Nili, Ariel Munitz, Zeev Zaslavsky, Itzhack Polacheck, Esther Segal*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Objectives: We developed a novel lipid formulation of nystatin suitable for parenteral administration, nystatin-intralipid (NYT-IL), with antifungal activity and reduced toxicity in mice. We investigated the pharmacokinetics, tissue distribution and immunomodulatory effect of NYT-IL in mice. Methods: Nystatin levels in serum and organs were determined using HPLC after NYT-IL or nystatin administration in mice. The levels of the pro-inflammatory cytokines tumour necrosis factor-α (TNF-α) and interferon-γ (IFN-γ) and the anti-inflammatory cytokine interleukin 10 (IL-10) produced by splenocytes from mice injected with NYT-IL or nystatin were evaluated by an ELISA assay. Results: Injection of NYT-IL resulted in similar levels and similar kinetics of nystatin in serum, higher concentrations in the liver and lower concentrations in the kidneys, in comparison with nystatin injection. Injection of mice with NYT-IL yielded higher levels of IL-10 than that of nystatin, whereas the levels of TNF-α and IFN-γ induced by NYT-IL were lower than those elicited by nystatin. Conclusions: Since polyene treatment is associated with nephrotoxicity, lower levels of nystatin in the kidneys following NYT-IL injection suggest the possibility of reduced toxicity. As the acute infusion-related adverse effects associated with polyene treatment are considered to be induced by pro-inflammatory cytokines, a higher level of anti-inflammatory and lower levels of pro-inflammatory cytokines elicited by NYT-IL administration suggest the possibility of amelioration of such effects. In summary, the altered pharmacokinetics, tissue distribution and immune response due to the use of this intralipid formulation of nystatin merit further research towards the development of a therapeutic agent against invasive mycoses.

Original languageEnglish
Article numberdks117
Pages (from-to)1716-1721
Number of pages6
JournalJournal of Antimicrobial Chemotherapy
Issue number7
StatePublished - Jul 2012


  • Cytokines
  • Nystatin-intralipid preparation
  • Pharmacological characteristics


Dive into the research topics of 'Pharmacokinetics, tissue distribution and immunomodulatory effect of intralipid formulation of nystatin in mice'. Together they form a unique fingerprint.

Cite this